The mix-up at the facility operated by contract manufacturer Emergent BioSolutions resulted in ingredients destined for AZ's AZD1222 jab being mixed into vials of the J&J product, rendering them ...

As part of the alliance VMIC and Oxford Biomedica will work together on the scale up and manufacture Oxford University and AstraZeneca’s coronavirus vaccine AZD1222 (formerly ChAdOx1 nCoV-19).

The adults were vaccinated with two doses of AZD1222/Covishield ( n = 77) [manufactured by Serum Institute of India Pvt Ltd] vaccine and BV152/Covaxin ( n = 99) [manufactured by Bharat Biotech] ...

Stroke risk also declined after the third dose (HR: 0.69; 95% CI: 0.63–0.74), with no significant differences between sexes or vaccine types, although AZD1222 showed slightly lower hazard ratios.

Eighty-nine (33.7%) patients received ChAdOx1 nCoV-19 (AZD1222) vaccine (AstraZeneca/Oxford) and 176 (66.3%) received mRNA-1273 (Moderna) vaccines. The median (IQR) ages were 50 years (39, 60) in ...

For example, Meeraus et al. analyzed over 4.5 million AZD1222 vaccine recipients and noted that VE against hospitalization was >90% in the lowest multimorbidity quartile compared to 80% in the highest ...